A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.
about
Function Over Form: Modeling Groups of Inherited Neurological Conditions in ZebrafishMutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease.Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.The 3-methylglutaconic acidurias: what's new?Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Leucine Loading Test is Only Discriminative for 3-Methylglutaconic Aciduria Due to AUH DefectAdditive reductions in zebrafish PRPS1 activity result in a spectrum of deficiencies modeling several human PRPS1-associated diseases.How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs.Optic atrophy, cataracts, lipodystrophy/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation.Disrupted mitochondrial function in the Opa3L122P mouse model for Costeff Syndrome impairs skeletal integrity.Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature.Mitochondrial Membrane Dynamics and Inherited Optic Neuropathies.On the origin of 3-methylglutaconic acid in disorders of mitochondrial energy metabolism3-Methylglutaconic aciduria--lessons from 50 genes and 977 patients.The neuropsychological profile of patients with 3-methylglutaconic aciduria type III, Costeff syndrome.
P2860
Q26741616-36B03B6E-9AF3-4CFE-A473-C8599853F2ACQ30506049-6F54EDD7-F7DC-4628-AB81-89E9F7B8A47FQ33590834-8F8477FF-0E13-417B-945F-D00751B9AB85Q34140909-BFCEF3A5-5F02-485E-9754-08FEB46B2C24Q34152110-2FF29400-445A-44C3-8669-216BBCE845EDQ34457690-A8A23B49-D09D-415C-92B2-3E4B3C4C0939Q34534367-D7409D57-C51C-4766-9210-3110EEAC1B31Q36965904-AB9F941E-1E8A-41D7-A16E-26F15D90D3A5Q37518618-686104A7-C076-487A-8B9C-CCACDE6804E8Q37530214-500AAEA9-1225-4E40-BA8D-7DDACC23741DQ38072306-73641E28-32E1-411E-B54D-F79F6CAF7029Q39399568-47EA3469-1C9A-48B7-8442-037F40BB1A9AQ41700092-B543DF4A-9F03-4B8A-9630-FEC437F0A169Q43976956-28953B25-999B-4BDF-9D32-E739571D9E38Q50602507-E797FF62-6C1C-4B4F-9451-A513EB803EEF
P2860
A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A model of Costeff Syndrome re ...... nctions of mitochondrial OPA3.
@ast
A model of Costeff Syndrome re ...... nctions of mitochondrial OPA3.
@en
type
label
A model of Costeff Syndrome re ...... nctions of mitochondrial OPA3.
@ast
A model of Costeff Syndrome re ...... nctions of mitochondrial OPA3.
@en
prefLabel
A model of Costeff Syndrome re ...... nctions of mitochondrial OPA3.
@ast
A model of Costeff Syndrome re ...... nctions of mitochondrial OPA3.
@en
P2093
P2860
P356
P1433
P1476
A model of Costeff Syndrome re ...... unctions of mitochondrial OPA3
@en
P2093
Carla Ciccone
Heidi Dorward
Isa Bernardini
Lisa E Kratz
Marjan Huizing
Raman Sood
Richard I Kelley
Tohei Yokogawa
Wuhong Pei
Yair Anikster
P2860
P304
P356
10.1242/DEV.043745
P407
P577
2010-08-01T00:00:00Z